Literature DB >> 8407555

Brefeldin A blocks the cytotoxicity of T cell receptor alpha/beta and gamma/delta cytotoxic T lymphocyte clones reacting against human autologous cancer cells.

Y Wada1, H Ikeda, D Ueda, M Ohta, S Takahashi, K Hirata, N Sato, K Kikuchi.   

Abstract

We studied the effector mechanism of T cell receptor (TCR) alpha/beta- and gamma/delta-type cytotoxic T lymphocyte (CTL) clones that react with human autologous tumor cells. Treatment of tumor cells with a fungal antibacterial reagent, brefeldin A (BFA), resulted in the inhibition of cytotoxicity of an autologous tumor (HST-2)-specific CD8+ TCR alpha/beta-type CTL, TcHST-2. Other anti-metabolites such as chloroquine, cycloheximide and colchicine did not affect the cytotoxicity. The cell-surface antigen expression, including MHC class I molecules, was not influenced by BFA treatment. Furthermore, BFA did not influence the cytotoxicity of lymphokine-activated killer cells and natural killer cells. Since BFA blocks the transport of peptides from endoplasmic reticulum to the Golgi apparatus, the above data suggest that BFA could affect washing out of the peptide fragments from the MHC class I groove. Consequently, target tumor cells were protected from killing by CTL. Moreover, we obtained a CD4-, 8-, TCR gamma/delta-type (V delta 1+) CTL clone, TcHOT, that reacts against an autologous ovarial carcinoma, HOT. BFA could also inhibit this cytotoxicity, and it is likely that different presenting molecules other than MHC class I proteins participate in the cytotoxicity of this TCR gamma/delta-type CTL. These studies suggest that both TCR alpha/beta- and gamma/delta-type CTL may require antigenic peptides that are most likely derived from the BFA-sensitive, intracellular endogenous target proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8407555      PMCID: PMC5919263          DOI: 10.1111/j.1349-7006.1993.tb02065.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


cytotoxic T lymphocytes brefeldin A mixed lymphocyte‐autologous tumor cell culture lymphokine‐activated killer natural killer T cell receptor recombinant interleukin major histocompatibility complex fluorescein‐activated cell sorter monoclonal antibody endoplasmic reticulum polymerase chain reaction antibody‐dependent cellular cytotoxicity peripheral blood lymphocytes
  45 in total

Review 1.  Pathways of viral antigen processing and presentation to CTL: defined by the mode of virus entry?

Authors:  E O Long; S Jacobson
Journal:  Immunol Today       Date:  1989-02

2.  Association of class I major histocompatibility heavy and light chains induced by viral peptides.

Authors:  A Townsend; C Ohlén; J Bastin; H G Ljunggren; L Foster; K Kärre
Journal:  Nature       Date:  1989-08-10       Impact factor: 49.962

3.  Identification of a protein altered in mutants resistant to microtubule inhibitors as a member of the major heat shock protein (hsp70) family.

Authors:  S Ahmad; R Ahuja; T J Venner; R S Gupta
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

Review 4.  Stress proteins and immunology.

Authors:  R A Young
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

5.  Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments.

Authors:  P A Reid; C Watts
Journal:  Nature       Date:  1990-08-16       Impact factor: 49.962

6.  Interaction of Staphylococcus aureus toxin "superantigens" with human T cells.

Authors:  Y W Choi; B Kotzin; L Herron; J Callahan; P Marrack; J Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

7.  Characterization of n-butyl alcohol solubilized, breast tumor specific antigens recognized by a human autologous cytotoxic T-cell clone.

Authors:  T Sato; N Sato; S Takahashi; M Okubo; A Yagihashi; T Torigoe; N Takahashi; M Okazaki; K Asaishi; K Kukuchi
Journal:  Cancer Res       Date:  1988-07-15       Impact factor: 12.701

8.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  P van der Bruggen; C Traversari; P Chomez; C Lurquin; E De Plaen; B Van den Eynde; A Knuth; T Boon
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

9.  MHC class II-restricted presentation of native protein antigen by B cells is inhibitable by cycloheximide and brefeldin A.

Authors:  Y St-Pierre; T H Watts
Journal:  J Immunol       Date:  1990-08-01       Impact factor: 5.422

10.  A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+WT31- lymphocytes to express their functional program(s).

Authors:  E Ciccone; S Ferrini; C Bottino; O Viale; I Prigione; G Pantaleo; G Tambussi; A Moretta; L Moretta
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more
  2 in total

1.  Cytotoxicity of histocompatibility leukocyte antigen-DR8-restricted CD4 killer T cells against human autologous squamous cell carcinoma.

Authors:  A Miyazaki; N Sato; S Takahashi; A Sasaki; G Kohama; A Yamaguchi; A Yagihashi; K Kikuchi
Journal:  Jpn J Cancer Res       Date:  1997-02

2.  T-cell receptor gene structures of HLA-A26-restricted cytotoxic T lymphocyte lines against human autologous pancreatic adenocarcinoma.

Authors:  D Ueda; N Sato; A Matsuura; A Sasaki; S Takahashi; H Ikeda; Y Wada; K Kikuchi
Journal:  Jpn J Cancer Res       Date:  1995-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.